• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic announces recent reimbursement wins for CGMs in a number of geographies

March 14, 2022 By Sean Whooley

Medtronic MiniMed 780G
The Medtronic MiniMed 780G system. [Image from Medtronic]
Medtronic (NYSE:MDT) announced today that reimbursement for its CGMs has been expanded or initiated across a number of countries.

Earlier this month, the Ontario, Canada provincial government announced a comprehensive reimbursement program for continuous glucose monitoring (CGM) for eligible residents who have type 1 diabetes, adding to a similar program for those with type 1 diabetes under 18 years old in Alberta, Canada.

At the end of 2021, the Colombian health benefit plan for 2022 was updated to include CGMs, making reimbursement no longer limited to approvals that were previously made on a case-by-case basis in the South American country, according to a news release.

Around the same time, in December 2021, the U.S. Centers for Medicare & Medicaid Services (CMS) expanded Medicare coverage for all kinds of CGMs, including those that integrate with Medtronic’s insulin pumps. At the time, analysts said that the new rule will likely bolster Medtronic’s Diabetes Business as a result of the expanded access to its diabetes technologies.

Finally, the company said that automated insulin pump reimbursement increased in Europe over the past several months, with Sweden reimbursing for the new Guardian 4 sensor with the MiniMed 780G system. Additionally, Croatia is fully reimbursing for the MiniMed 640G system with no limitations and reimbursing for MiniMed 780G with a copayment, while Estonia started reimbursement for 780G for people under 19 years old.

“It’s encouraging to see an increase in diabetes technology gaining reimbursement around the world,” Medtronic Diabetes VP of Health Economics, Reimbursement and Government Affairs Jeff Farkas said in the release. “We want people living with diabetes to have access to the therapies that best meet their diabetes management needs. Making it easier for people to get diabetes management technology helps improve control of this challenging disease and helps people live with less everyday worry about a chronic condition.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS